Literature DB >> 8093241

Characterization of cathepsin B specificity by site-directed mutagenesis. Importance of Glu245 in the S2-P2 specificity for arginine and its role in transition state stabilization.

S Hasnain1, T Hirama, C P Huber, P Mason, J S Mort.   

Abstract

The pH dependence of cathepsin B-catalyzed hydrolyzes is very complex. At least seven dissociable groups are involved in the binding and hydrolysis of 7-amido-4-methyl coumarin and p-nitroaniline (pNA)-based substrates containing a P1 Arg and either a Phe or Arg at the P2 position. By site-directed mutagenesis we show that a previous suggestion, that Arg202 is one of the groups which influences the pH dependence of cathepsin B-catalyzed hydrolysis of the Z-Arg-Arg-pNA substrate, is not valid. However, it was found that Glu245, which has a pKa of 5.1 in rat cathepsin B, is responsible for the S2-P2 specificity for Arg-containing substrates and controls the pH dependence of their hydrolysis. Furthermore, the data indicate that Glu245, which forms a hydrogen bond with the guanidinium group of the substrate's P2 Arg, contributes about 1.8 kcal/mol to transition state stabilization in the protonated state and about 0.6 kcal/mol in the deprotonated state. Mutation of Glu245 to Gln results in a 16-fold decrease in kcat but does not affect Km. While cathepsin B has a 7-fold preference for Phe over Arg at the P2 position of a substrate, binding of the aromatic side chain does not appear to be influenced by Glu245.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8093241

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Expression and alteration of the S2 subsite of the Leishmania major cathepsin B-like cysteine protease.

Authors:  V J Chan; P M Selzer; J H McKerrow; J A Sakanari
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

2.  Identification of lead compounds targeting the cathepsin B-like enzyme of Eimeria tenella.

Authors:  Marie Schaeffer; Joerg Schroeder; Anja R Heckeroth; Sandra Noack; Michael Gassel; Jeremy C Mottram; Paul M Selzer; Graham H Coombs
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

3.  Structural basis for inhibition of cathepsin B drug target from the human blood fluke, Schistosoma mansoni.

Authors:  Adéla Jílková; Pavlína Rezácová; Martin Lepsík; Martin Horn; Jana Váchová; Jindrich Fanfrlík; Jirí Brynda; James H McKerrow; Conor R Caffrey; Michael Mares
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

4.  S2' substrate specificity and the role of His110 and His111 in the exopeptidase activity of human cathepsin B.

Authors:  Joanne C Krupa; Sadiq Hasnain; Dorit K Nägler; Robert Ménard; John S Mort
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

5.  Cathepsin B: Basis Sequence: Mouse.

Authors:  Dora Cavallo-Medved; Kamiar Moin; Bonnie Sloane
Journal:  AFCS Nat Mol Pages       Date:  2011-04-10

6.  Design of cell-permeable, fluorescent activity-based probes for the lysosomal cysteine protease asparaginyl endopeptidase (AEP)/legumain.

Authors:  Kelly B Sexton; Martin D Witte; Galia Blum; Matthew Bogyo
Journal:  Bioorg Med Chem Lett       Date:  2006-11-06       Impact factor: 2.823

7.  Cathepsin B carboxydipeptidase specificity analysis using internally quenched fluorescent peptides.

Authors:  Maria Helena S Cezari; Luciano Puzer; Maria Aparecida Juliano; Adriana K Carmona; Luiz Juliano
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

8.  Molecular and biochemical characterization of a cathepsin B-like protease family unique to Trypanosoma congolense.

Authors:  Carlos Mendoza-Palomares; Nicolas Biteau; Christiane Giroud; Virginie Coustou; Theresa Coetzer; Edith Authié; Alain Boulangé; Théo Baltz
Journal:  Eukaryot Cell       Date:  2008-02-15

9.  Crystal Structures of TbCatB and rhodesain, potential chemotherapeutic targets and major cysteine proteases of Trypanosoma brucei.

Authors:  Iain D Kerr; Peng Wu; Rachael Marion-Tsukamaki; Zachary B Mackey; Linda S Brinen
Journal:  PLoS Negl Trop Dis       Date:  2010-06-08

10.  E64 [trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane] analogues as inhibitors of cysteine proteinases: investigation of S2 subsite interactions.

Authors:  B J Gour-Salin; P Lachance; M C Magny; C Plouffe; R Ménard; A C Storer
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.